A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
First approved CRISPR‑Cas9 gene‑editing therapy for sickle cell disease and β‑thalassemia
This milestone was not a bench research article per se, but it was published and highlighted in Nature as a historic biotechnology advance in the editorial and commentary sections of the journal: the approval of…
-
Uncovering the functional diversity of rare CRISPR-Cas systems with deep terascale clustering
Journal: Science Volume/Issue: 382 (Issue 6673) Publication Date: November 24, 2023 (published online November 23) DOI: 10.1126/science.adi1910 Authors: Han Altae-Tran, Soumya Kannan, Anthony J. Suberski, Kepler S. Mears, F. Esra Demircioglu, Lukas Moeller, Selin Kocalar,…
-
A monomeric StayGold fluorescent protein
Journal: Nature Biotechnology Publication Date: 11 December 2023 (online) DOI: 10.1038/s41587-023-02018-w Type: Research article / brief communication What the paper reports This study describes the development of mStayGold, a monomeric version of the highly bright…
